The PCI Center

Filter Your Results

 

News

 

European Registry Results Presented for Boston Scientific's Watchman LAAC Device

May 12, 2017 -- Boston Scientific Corporation announced positive safety and efficacy rates of the Watchman left atrial appendage closure device from the EWOLUTION registry, wh…

Real-World PRECISION Registry Evaluates Robotic PCI With Corindus' CorPath 200

May 12, 2017 -- Final results of the multicenter real-world PRECISION registry, which is evaluating the safety and efficacy outcomes of radial access versus femoral …

ARIC Analysis Shows Early Revascularization for NSTEMI Patients Results in Increased Survival

May 12, 2017 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced that results from the Atherosclerosis Risk in Communities (ARIC) surveillance stu…

Postapproval Registry Data Presented for Medtronic's Micra TPS

May 11, 2017 -- Medtronic announced preliminary results for the Medtronic Micra transcatheter pacing system (TPS) postapproval registry, which demonstrated a 99.6% implantatio…

Abiomed Introduces Third-Generation Impella CP Heart Pump

May 10, 2017 -- Abiomed, Inc. announced the introduction of the third-generation Impella CP heart pump at SCAI 2017, the annual meeting of the Society for Cardiovascular and A…

Long-Term Safety and Efficacy of Bioresorbable Vascular Scaffolds Versus Metallic Stents Compared in Meta-Analysis

May 8, 2017 -- A meta-analysis of randomized trials evaluating the long-term safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds (BVS) versus everolimus…

First Patient Enrolled in Abiomed's STEMI DTU Feasibility Study

May 5, 2017 -- Abiomed, Inc. announced the enrollment of the first patient in the prospective feasibility study of ST-segment elevation myocardial infarction (STEMI) door to u…

Medtronic Launches Resolute Onyx Drug-Eluting Stent in United States

May 1, 2017 -- Medtronic announced the US Food and Drug Administration (FDA) approval and the United States launch of the Resolute Onyx drug-eluting stent (DES). The Reso…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.